BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  QIAGEN beats outlook for fourth quarter and full-year 2021, delivers 22% CER full-year sales growth from non-COVID products

  QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the fourth quarter and full-year 2021.

  February 8, 2022

   · 

  6 min read
• Genetown

  Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference

  Abiomed, Inc. announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will hold a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 10:40am.

  February 8, 2022

   · 

  2 min read
• Business

  Zoetis Declares Second Quarter 2022 Dividend

  The Board of Directors of Zoetis Inc. has declared a dividend of $0.325 per share for the second quarter of 2022.

  February 8, 2022

   · 

  2 min read
• Business

  Electromed, Inc. Announces Second Quarter 2022 Financial Results

  Record quarterly net revenues of $10.2 million while continuing to execute key strategic growth initiatives

  February 8, 2022

   · 

  10 min read
• Biotech Beach

  Ra Medical Systems, Inc. Announces Closing of $12.1 Million Underwritten Public Offering

  Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, today announced the closing of an underwritten public offering of units and pre-funded units for aggregate gross proceeds of approximately $12.1 million.

  February 8, 2022

   · 

  2 min read
• Business

  Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results

  Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the fourth quarter and year ended December 31, 2021, and provided a corporate update.

  February 8, 2022

   · 

  14 min read
• Business

  Zymeworks to Host Fourth Quarter and Full Year 2021 Results Conference Call

  Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its fourth quarter and full year 2021 financial results after market close on February 24th, 2022.

  February 8, 2022

   · 

  2 min read
• Business

  Iterative Scopes Announces AI-Driven Data Sharing Agreement with Pfizer to Advance IBD Clinical Trials

  Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that it has entered into a data sharing agreement with Pfizer, a leader in innovative IBD research.

  February 8, 2022

   · 

  3 min read
• Pharm Country

  Sectra Wins Four 2022 Best In KLAS Awards In The US, Canada, And Asia/Oceania

  International medical imaging IT and cybersecurity company Sectra announces that its radiology module for enterprise imaging, Sectra PACS, has won the prestigious customer satisfaction award Best in KLAS.

  February 8, 2022

   · 

  2 min read
• Genetown

  BostonGene Expands Testing Capabilities to Predict Patient Response to Immunotherapy

  BostonGene Corporation announced today expanded capabilities of the BostonGene Tumor Portrait TM Test that enable healthcare providers and insurance companies to determine eligibility and predict response for immunotherapy treatment and manage the total cost of care for cancer patients.

  February 8, 2022

   · 

  3 min read